PARP Inhibitors in Ovarian Cancer: The SOLO-3 Trial

Video

Shannon N. Westin, MD, MPH, FACOG, explains the study design and outcomes of the SOLO-3 trial.

Related Videos
A panel of 4 experts on MDS
A panel of 4 experts on MDS
A panel of 6 experts on follicular lymphoma and mantle cell lymphoma seated at a long desk
A panel of 5 experts on multiple myeloma
A panel of 5 experts on multiple myeloma
Robert DeBernardo, MD, section head, Obstetrics and Gynecology, Women’s Health Institute, Cleveland Clinic
A panel of 4 experts on hematologic malignancies
A panel of 6 experts on chronic lymphocytic leukemia seated at a long desk